Eli Lilly's Weight Loss Med Tirzepatide Gets Endorsement From U.K.'s NICE

Seeking Alpha00:35

With EPS Growth And More, Eli Lilly (NYSE:LLY) Makes An Interesting Case

Yahoo Finance12/24 20:00

Eli Lilly's Anti-Obesity Drug Mounjaro to Be Supported by UK Public Health System for Some Patients

MT Newswires12/24 19:07

昨夜,苹果历史新高!

証券時報12/24 08:05

Sector Update: Health Care Stocks Advance Late Afternoon

MT Newswires12/24 04:59

Ely Lilly Shares Are Trading Higher After the FDA Approved the Company's Zepbound, a Weight Loss Drug Designed to Treat Moderate-to-severe Obstructive Sleep Apnea in Adults With Obesity.

Benzinga12/24 04:45